How to Build Your Own CTO PCI Program

Slides:



Advertisements
Similar presentations
A multicenter, randomized, prospective DKCRUSH-III study
Advertisements

Randomized Comparison of FFR-guided and Angiography-guided Provisional Stenting for True Coronary Bifurcation Lesions: The DKCRUSH-VI trial Shao-Liang.
CORONARY PRESSURE MEASURENT AND FRACTIONAL FLOW RESERVE
WG Hellenic PCI Registry Organization - Structure - Directions - Initial Recordings Georgios I. Papaioannou, MD,
Chaim Lotan MD, Yaron Almagor MD, Karel Kuiper MD, M.J. Suttorp MD, William Wijns MD The SICTO Study CYPHER TM Sirolimus-eluting stent in Chronic Total.
ICE Hellenic PCI Registry Organization - Structure - Directions - Initial Recordings Georgios I. Papaioannou, MD,
The Synergy between Percutaneous Coronary Intervention with TAXUS and Cardiac Surgery: The SYNTAX Study One Year Results of the PCI and CABG Registries.
Retrograde Percutaneous Recanalization Of Coronary Chronic Total Occlusions: Outcomes And Technical Tips & Tricks From 17 Patients G. BIONDI-ZOCCAI, C.
Left Main Trifurcation Disease: Early and Long-Term Outcomes Of Percutaneous Coronary Intervention I.Sheiban, A.Gerasimou, F. Sciuto, P.Omedè, G. Biondi.
Retrograde approach for the Recanalizaiton of Coronary CTO: Preliminary Experience of Single Centre Lei Ge, Juying Qian, Xuebo Liu, Qin Qing, Junbo Ge.
ΕΚΕ Hellenic PCI Registry ( ) Περιεχόμενο και αναγκαιότητα διατήρησης Registry Αγγειοπλαστικής Georgios.
David Hildick-Smith Sussex Cardiac Centre. Background to ARTS Previous POBA studies Meta-analysis 3300 patients 1660 CABG, 1710 PTCA Deaths 79 PCI vs.
Using a deflectable tipped Catheter to treat previously inaccessible lesions Helen Routledge Interventional Fellow Institut Cardiovasculaire Paris Sud.
The SAFER Trial Evaluation of the Clinical Safety and Efficacy of the PercuSurge GuardWire in Saphenous Vein Graft Intervention As presented at TCT 2000.
Chronic Total Occlusions
Date of download: 6/2/2016 Copyright © The American College of Cardiology. All rights reserved. From: Retrograde Techniques and the Impact of Operator.
St Asaph - November 2015 Dr Richard Anderson Consultant Cardiologist Senior Lecturer University Hospital of Wales, Cardiff, UK Wales Audit Data
Patients, Procedures, and Patient Reported Health Status A First Report from the OPEN CTO Trial Investigators J. Aaron Grantham, MD, FACC Saint Luke’s.
Disclosure Statement of Financial Interest
Date of download: 7/7/2016 Copyright © The American College of Cardiology. All rights reserved. From: In-Hospital Outcomes of Contemporary Percutaneous.
Philippe Généreux, MD for the Tryton Bifurcation Trial Investigators Columbia University Medical Center Cardiovascular Research Foundation New York City.
Review of Common & Uncommon CTO Complications
The Endocross Enabler-P: First in-Human Results
The OPTIMAX first-in-man study Mid-term clinical outcome of Titanium-Nitride-Oxide-coated Cobalt Chromium stents in patients with de novo coronary artery.
The Society for Cardiovascular Angiography & Interventions (SCAI) Foundation Charles E. Chambers, MD, FSCAI President Elect, Society for Cardiovascular.
A new technique of IVUS guided CTO PCI
Disrupt CAD Study Design
G. Capretti, M. Carlino, A. Colombo, L. Azzalini
Successful transdradial removal of a dislodged coronary stent
Transradial Intervention: Complex Case Review Yes, They Can Be Done!
1-year Outcome of The Italian Registry on Chronic Total Occlusion:
Emory University School of Medicine
Strategies to Improve Inadequate Guide Catheter Support
European Registry Update
Clinical Presentation
The Spectrum of Guidewires Available to Recanalize CTO and How to Choose the Wire/Device Hybrid CTO PCI 2011 Craig A. Thompson, M.D., MMSc. Director, Invasive.
The Radial Approach for CTO PCI Utility in the Retrograde and the Antegrade Approaches Shigeru Saito, MD, FACC, FSCAI, FJCC Shonan Kamakura General Hospital.
Treating CTOs Is there evidence based data?
Intraluminal Coronary Reentry results of the US IDE Trial for the Bridgepoint Medical Crossboss and Stingray Systems Craig A. Thompson, M.D., MMSc. Director,
David J. Cohen, M.D., M.Sc. Director of Cardiovascular Research
Why Radial Access Should be the Default for Women undergoing PCI?
CTO Perspectives: When not to Start, and When to Stop and Try Again
9:00 AM-9:05 AM, Tuesday, Oct. 31; Room 201/203
Crossing CTOs via Planned Dissection: LaST (Limited Antegrade Subintimal Tracking): from knuckle wire to Bridgepoint Craig A. Thompson, M.D., MMSc. Director,
Scenario 1: Diagnostic No PCI Required
BVS Expand: First Results of Wide Clinical Applications
Subintimal Tracking and Reentry for CTO STAR Method
Crossing CTOs via Planned Dissection: LaST (Limited Antegrade Subintimal Tracking): from knuckle wire to Bridgepoint Craig A. Thompson, M.D., MMSc. Director,
OCT-Guided PCI What needs to be done to establish criteria?
The Hybrid approach to CTO PCI
Interesting Case Review
Essesntials for CTO Recanalization
Newer methods to Facilitate the Retrograde Approach
MACE Trial Rationale, Study Design, and Current Status
POISE-2 PeriOperative ISchemic Evaluation-2 Trial
Circ Cardiovasc Interv
Using Coronary CTA to Guide Intervention for CTO
Kyoto University Hospital, Japan
for the SPIRIT IV Investigators
Long Term Safety and Effectiveness of XIENCE V® Everolimus Eluting Coronary Stent System in a Real-World Population: Three-Year Clinical Outcomes from.
The Synergy between Percutaneous Coronary Intervention with TAXUS and Cardiac Surgery: The SYNTAX Study One Year Results of the PCI and CABG Registries.
SIRIUS: A U.S. Multicenter, Randomized, Double-Blind Study of the SIRolImUS-Eluting Stent in De Novo Native Coronary Lesions Presented at TCT 2002.
STENT THROMBISIS Insights on Outcomes and Impact of DUAL ANTIPLATELET THERAPY Permanent Discontinuation SPIRIT II, SPIRIT III, SPIRIT IV and COMPARE.
Hellenic PCI Registry Organization - Structure - Directions - Initial Recordings Georgios I. Papaioannou, MD, MPH, FACC,
Incidence and management of restenosis after treatment of unprotected left main disease with drug-eluting stents: 70 restenotic cases from a cohort of.
for the SPIRIT IV Investigators
What oral antiplatelet therapy would you choose?
The Synergy between Percutaneous Coronary Intervention with TAXUS and Cardiac Surgery: The SYNTAX Study One Year Results of the PCI and CABG Registries.
ISAR-LEFT MAIN: A Randomized Clinical Trial on Drug-Eluting Stents for Unprotected Left Main Lesions J. Mehilli, MD Deutsches Herzzentrum Technische.
Atlantic Cardiovascular Patient Outcomes Research Team
Presentation transcript:

How to Build Your Own CTO PCI Program Barry D. Rutherford, MD CRT 2012

How to Build Your Own CTO PCI Program Attract some important and skilled friends Create a CTO Day Educate your partners and particularly your surgical colleagues Create a referral base CTO mini courses CTO clubs Visiting skilled operators Attend national and international meetings

Attract some important and skilled friends Ken Huber Chuck Barth Osamu Katoh BDR Masahiko Ochiai

Hideo Tamai, MD & Osamu Katoh, MD

440 Institutions Reported 737,675 Cases to ACC/NCDR V3.04 The Influence of Operator Volume on Attempt Rate of Percutaneous Coronary Intervention for CTO 440 Institutions Reported 737,675 Cases to ACC/NCDR V3.04 39,502 patients with CTO PCI to the 100% Occlusion Within 90 Days? Yes No 6,331 (16%) 33,171 Excluded from Data: Recent MI, Indication for Surgery, Prior CABG, Shock

Chronic Total Coronary Occlusion Low Attempt Rates Fear of failure Complications Doubt regarding long term results Time and cost constraints Radiation exposure — patient and operator Apathy

How to Build Your Own CTO PCI Program CTO Day 1-2 days per month Dedicated lab, senior technicians Two interventional cardiologists 4 CTO cases per day 4-6 visiting physicians Lecture, case review, handout materials Industry support Utilization of new technology

How to Build Your Own CTO PCI Program No Ad hoc procedures Detailed angiographic evaluation Proximal cap Distal cap Length of lesion Angulation of lesion Calcification Collaterals (septals, epicardials, and SVGs)

How to Build Your Own CTO PCI Program CTO Cart Guides/GuideLiner Wires Delivery Catheters Snares Balloons Coils

How to Build Your Own CTO PCI Program

How to Build Your Own CTO PCI Program

Educate your partners and surgical colleagues on how to evaluate the CTO Angiogram

CTOFundamentals.org Founders Aaron Grantham, Bill Lombardi, Craig Thompson Faculty Mike Wyman, Tony DeMartini, Nick Burke, James Spratt, Ashish Pershad, Nick Lembo, Dimitri Karmapliotis, Stéphane Rinfret, Pat Whitlow, Format US 501c(3) NFP under the MAHI Foundation Educational grant funded from industry IT partnership with Socius Medical, Inc

CTOFundamentals.org Mission An online resource for CTO operators; novices, and experts, to systematically teach techniques and technologies that enhance procedural success and safety in CTO-PCI Format CTO University 13 didactic lectures, case examples CTO Community Online sharing and interactive mentoring Go Live 3/1/2012, register today @ CTOFundamentals.org

Bellingham, WA January 2011 17 patients from 6 states (9 previous failures) 13 physicians 5 CTO operators working in pairs C Thompson, B Lombardi, A Grantham, T DeMartini, M Wyman Strategy determined by group blinded to operator assignment Hybrid approach Initial strategy/device Time and progress parameters to switch strategies Operator unblinding immediately prior to case Primary and secondary operator Execute assigned strategy

Baseline Demographics, 17 pts Bellingham, WA CTO Workshop – January 2011 Mean age (yrs) 63.7 Gender (M) 94% Prior CABG 35% CTO location LAD 47% RCA 29% LCx 24% Previous failure 53% Lesion Length (mm) 23.5 Proximal RVD (mm) 2.89mm Distal RVD (mm) 2.60mm

Procedure Outcomes Bellingham, WA CTO Workshop – January 2011 EFFICIENCY Case time (mean) 89.9 min Cases < 2hrs 82% Contrast 273.5 cc Fluoro Time 39.6 min EFFECTIVENESS Technical Success 100% SAFETY MACE 5.8% (perf) Death/MI 0%

THANK YOU